About Abcodia
Abcodia is a company based in Cambridge (United Kingdom) founded in 2010 was acquired by GEN inCode in September 2022. It operates as a B2B. Abcodia has raised $9.87 million across 4 funding rounds from investors including GEN inCode, European Union and UCL Technology Fund. The company has 4 employees as of June 30, 2021. Abcodia offers products and services including ROCA Test. Abcodia operates in a competitive market with competitors including Guardant Health, GRAIL, Natera, Foundation Medicine and ArcherDX, among others.
- Headquarter Cambridge, United Kingdom
- Employees 4 as on 30 Jun, 2021
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Abcodia Limited
- Date of Incorporation 22 Sep, 2010
- Jurisdiction MANCHESTER, UNITED KINGDOM
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$9.87 M (USD)
in 4 rounds
-
Latest Funding Round
$8.25 M (USD), Series A
May 18, 2015
-
Investors
GEN inCode
& 5 more
-
Employee Count
4
as on Jun 30, 2021
-
Acquired by
GEN inCode
(Sep 28, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Abcodia
Abcodia offers a comprehensive portfolio of products and services, including ROCA Test.
Screening tool for early detection of ovarian cancer risks.
People of Abcodia
Unlock access to complete
Unlock access to complete
Leadership Team
7 people
Finance and Accounting
1 people
Software Development Team
1 people
Chairman Team
1 people
Unlock access to complete
Funding Insights of Abcodia
Abcodia has successfully raised a total of $9.87M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $8.25 million completed in May 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Abcodia
Abcodia has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include GEN inCode, European Union and UCL Technology Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on tech companies
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Venture capital firm focused on physical and life sciences companies
|
Locked | Locked | Locked |
Investor details for Abcodia
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Abcodia
Investment portfolio details for Abcodia
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Abcodia
Detailed financials for Abcodia
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Abcodia Comparisons
Peer comparison for Abcodia
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Abcodia
Abcodia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, GRAIL, Natera, Foundation Medicine and ArcherDX, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital sequencing technology for cancer detection is developed.
|
|
| Locked | Locked | Locked |
Circulating tumor DNA is screened for early cancer detection.
|
|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Health risks are identified through online genetic and diagnostic testing.
|
Detailed competitors of Abcodia
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Abcodia
Complete news archive for Abcodia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abcodia
Abcodia was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Abcodia is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Abcodia is a funded company, having raised a total of $9.87M across 4 funding rounds to date.
As of Jun 30, 2021, the latest employee count at Abcodia is 4.
ROCA specializes in diagnostic testing for ovarian cancer, offering tools like the ROCA Test to detect risks early through blood analysis. It serves clinicians with resources for patient care and provides educational content on topics such as BRCA mutations. The platform includes FAQs, news, blogs, and guidelines to enhance awareness, though specific locations are not detailed. It targets healthcare professionals and at-risk patients for improved outcomes.
Abcodia's top competitors include Guardant Health, GRAIL and Foundation Medicine.
Abcodia offers ROCA Test.
Abcodia has 6 investors. Key investors include GEN inCode, European Union, UCL Technology Fund, Scottish Equity Partners, and Cambridge Innovation Capital.